Applied dna and evvivax initiate phase i of clinical trial to evaluate lineardna™ covid-19 vaccine candidate for feline veterinary market

Stony brook, n.y. & rome--(business wire)---- $apdn #covid19--if the veterinary vaccine candidate demonstrates effectiveness, the two companies intend to apply to usda to enable commercial vet sales under aphis.
APDN Ratings Summary
APDN Quant Ranking